1. Dharmage SC, Perret JL, Custovic A. Epidemiology of Asthma in Children and Adults. Front. Pediatr. 2019;7:246.
2. Ferrante G, La Grutta S. The Burden of Pediatric Asthma. Front. Pediatr. 2018;6:186.
3. Pearce N, Aït-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, Robertson C, and the ISAAC Phase Three Study Group. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2007;62:758-66.
4. Soto-Martínez ME, Soto-Quiros ME, Custovic A. Childhood Asthma: Low and Middle-Income Countries Perspective. Acta Med Acad. 2020;49(2):181-90.
5. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2021. A
6. Carr TF, Bleecker E. Asthma heterogeneity and severity. World Allergy Organ J. 2016;29;9(1):41.
7. Bonato M, Tiné M, Bazzan E, Biondini D, Saetta M, Baraldo S. Early Airway Pathological Changes in Children: New Insights into the Natural History of Wheezing. J Clin Med. 2019;8(8):1180.
8. Pijnenburg MW, Frey U, De Jongste JC, Saglani S. Childhood asthma: pathogenesis and phenotypes. Eur Respir J. 2022 9;59(6):2100731.
9. Comberiati P, Di Cicco ME, D'Elios S, Peroni DG. How Much Asthma Is Atopic in Children? Front Pediatr. 2017;5(3):122.
10. Di Cicco M, D'Elios S, Peroni DG, Comberiati P. The role of atopy in asthma development and persistence. Curr Opin Allergy Clin Immunol. 2020;20(2):131-137.
11. Caminati M, Pham DL, Bagnasco D, Canonica GW. Type 2 immunity in asthma. World Allergy Organ J. 2018;11(1):13.
12. Jo-Watanabe A, Okuno T, Yokomizo T. The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders. Int J Mol Sci. 2019 Jul 22;20(14):3580.
13. Trinh HKT, Lee SH, Cao TBT, Park HS. Asthma pharmacotherapy: an update on leukotriene treatments. Expert Rev Respir Med. 2019 Dec;13(12):1169-78.
14. Marcello C, Carlo L. Asthma phenotypes: the intriguing selective intervention with Montelukast. Asthma Res Pract. 2016;2:11.
15. Tesse R, Borrelli G, Mongelli G, Mastrorilli V, Cardinale F. Treating Pediatric Asthma According Guidelines. Front Pediatr. 2018;6(5)234.
16. Nagao M, Ikeda M, Fukuda N, Habukawa C, Kitamura T, Katsunuma T, Fujisawa T; LePAT (Leukotriene and Pediatric Asthma Translational Research Network) investigators. Early control treatment with montelukast in preschool children with asthma: A randomized controlled trial. Allergol Int. 2018;67(1):72-8.
17. Ramsay CF, Pearson D, Mildenhall S, Wilson AM. Oral montelukast in acute asthma exacerbations: a randomised, double-blind, placebo-controlled trial. Thorax. 2011 Jan;66(1):7-11.
18. Chaudhury A, Gaude GS, Hattiholi J. Effects of oral montelukast on airway function in acute asthma: A randomized trial. Lung India. 2017;34(4):349-54.
19. Wang X, Zhou J, Zhao X, Yi X. Montelukast Treatment of Acute Asthma Exacerbations in Children Aged 2 to 5 Years: A Randomized, Double-Blind, Placebo-Controlled Trial. Pediatr Emerg Care. 2018 Mar;34(3):160-4.
20. Harmanci K, Bakirtas A, Turktas I, Degim T. Oral montelukast treatment of preschool-aged children with acute asthma. Ann Allergy Asthma Immunol. 2006;96(5):731-5.
21. Magazine R, Surendra VU, Chogtu B. Comparison of oral montelukast with oral ozagrel in acute asthma: A randomized, double-blind, placebo-controlled study. Lung India. 2018 Jan-Feb;35(1):16-20.
22. Green SA, Malice MP, Tanaka W, Tozzi CA, Reiss TF. Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation. Thorax. 2004 Feb;59(2):100-4.